Pillsbury advised Cercle, an AI technology company unlocking comprehensive and secure data insights for the healthcare industry, in its recent launch and seed funding round.

The total amount of seed funding has not been disclosed.

Former Meta COO Sheryl Sandberg and former Kelton Global CEO Tom Bernthal served as lead investors via their venture fund, Sandberg Bernthal Venture Partners.

Focused on advancing fertility and women’s healthcare, Cercle harnesses the power of AI to secure data-driven biomedical and genomics healthcare insights for clinics, research labs, providers and patients with their Cercle™ Biomedical Graph. According to a company press release, the graph’s results will help provide more individualized and precise treatment plans and patient recommendations based on the anonymized medical histories of a diverse base of patients from around the world.

Click here to read the full press release.

The Pillsbury deal team included Corporate partner Allison Leopold Tilley, attorney Lisa Higa and senior legal analyst Seetha Balasubramanian.